Beeld op de omslag

Present and Future of Personalised Medicine for Endocrine Cancers

Major technological advances in genomics have made it possible to identify critical genetic alterations in cancer, rendering oncology well along the path to “personalised cancer medicine”. Thanks to developments in genetics, several mutations and gene rearrangements have been identified in patients...

Volledige beschrijving

Bewaard in:
Formaat: Online
Taal:Engels
Gepubliceerd in: MDPI - Multidisciplinary Digital Publishing Institute 2022
Onderwerpen:
papillary thyroid cancer
SUV PET/CT
BRAF V600E
immune checkpoint inhibitors (ICIs)
ipilimumab
nivolumab
prolactinoma
Cushing’s disease
aggressive pituitary tumor
aggressive PitNET
aggressive pituitary adenoma
pituitary carcinoma
adrenocortical cancer
adrenal adenomas
adrenal tumors
p53
p27
ki-67
reticulin
mitotane
adjuvant treatment
recurrence
recurrence free survival
timing
intratumoral heterogeneity
thyroid tumor
BRAF
RET/PTC rearrangements
RAS mutation
adrenal cortex
carcinoma
angiogenesis
gene expression
osteopontin
hyaluronan synthase 1
multikinase inhibitors
sorafenib
lenvatinib
differentiated thyroid cancer
radioiodine resistance
predictive marker
predictors
response to treatment
survival
information needs and preferences
focus group interview
personalized medicine
neuroendocrine tumours
phaeochromocytoma
paraganglioma
molecular clusters
n/a
thema EDItEUR::M Medicine and Nursing
Online toegang:ONIX_20220621_9783036543307_91
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

ONIX_20220621_9783036543307_91

Gelijkaardige items